Acquis Managing Director Zach Fink joined Dr. Beatrice Anduze-Faris on “The 3 Things with Dr. B” podcast to discuss serendipity, purpose, and humanity.
In a wide-ranging conversation, Zach shared compelling perspectives on organizational transformation, personal growth, and the future of technology. Drawing from his extensive experience working with major healthcare, telecommunications, and consumer goods companies, Zach advocates for a fundamental shift in how we approach both corporate strategy and personal development.
One of Zach’s most impactful insights centers on the relationship between strategy and change. “Most companies are operating off a scorecard and list of transformations, but they’re not looking at how those transformations will work together to help them evolve as a company,” he observes. Rather than viewing transformation as discrete projects with clear endpoints, Zach argues for seeing change as continuous evolution. “We need to get away from the word transformation,” Zach shares. “It assumes a start and end – but change is constant.”
The perspectives Zach shares offer valuable insights for both organizational leaders and individuals seeking to navigate today’s rapidly changing landscape. His emphasis on coordination, continuous evolution, and authentic self-reflection provides a framework for thinking about transformation that goes beyond traditional change management approaches to embrace a more holistic and sustainable vision of progress.
Reach out to the Acquis team
Tags:
Procurement used to be the department of “no.” A checkpoint before spend approval charged with enforcing compliance, checking contracts, and cutting costs. Necessary, yes. Strategic? Hardly. That model no longer holds.
Read More
For decades, procurement and finance have been uneasy allies. One holds the purse strings. The other spends the money. In theory, they share the same goals. In reality, they often operate at cross-purposes — slowing each other down, duplicating efforts, and moving out of sync.
Read More
Over the next decade, biopharma success will be determined not by the most ambitious science or the largest balance sheets, but by leadership — specifically, by companies that can navigate the industry's bifurcation and develop fluency in the Alliance Economy. Others will likely face acquisition or marginalization.
Read More
Procurement used to be the department of “no.” A checkpoint before spend approval charged with enforcing compliance, checking contracts, and cutting costs. Necessary, yes. Strategic? Hardly. That model no longer holds.
Read More
For decades, procurement and finance have been uneasy allies. One holds the purse strings. The other spends the money. In theory, they share the same goals. In reality, they often operate at cross-purposes — slowing each other down, duplicating efforts, and moving out of sync.
Read More
Over the next decade, biopharma success will be determined not by the most ambitious science or the largest balance sheets, but by leadership — specifically, by companies that can navigate the industry's bifurcation and develop fluency in the Alliance Economy. Others will likely face acquisition or marginalization.
Read More
